Schedule 13G ownership disclosure

GLOBAL PHARMACEUTICAL CORP \DE\

Security class unavailable · CUSIP: 45256B101

Event date: 2016-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,045,960
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000914208-17-000192
Form type
SC 13G/A
Filer
Impax Laboratories, LLC
CIK
CIK 1003642
Filed
Feb 08, 2017
Reporting period
Dec 30, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub